<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>PURPOSE: To report our experience with intravitreal triamcinolone acetonide (IVTA) injections for the treatment of sight-threatening <z:e sem="disease" ids="C0235812" disease_type="Disease or Syndrome" abbrv="">vitritis</z:e> </plain></SENT>
<SENT sid="1" pm="."><plain>DESIGN: Interventional case series </plain></SENT>
<SENT sid="2" pm="."><plain>METHODS: Three patients with <z:hpo ids='HP_0011009'>acute</z:hpo> severe exacerbations of noninfectious <z:hpo ids='HP_0012121'>panuveitis</z:hpo> and <z:e sem="disease" ids="C0235812" disease_type="Disease or Syndrome" abbrv="">vitritis</z:e> were treated with IVTA injections alone or as an adjunct to systemic <z:chebi fb="1" ids="35705">immunosuppressive agents</z:chebi> </plain></SENT>
<SENT sid="3" pm="."><plain>RESULTS: Rapid clearance of the vitreous <z:mp ids='MP_0001845'>inflammation</z:mp> with improvement in visual acuity was observed 1 to 2 weeks after injection </plain></SENT>
<SENT sid="4" pm="."><plain>The effect lasted 2 to 6 months, with the shortest duration in the vitrectomized eye of Patient 1 </plain></SENT>
<SENT sid="5" pm="."><plain>Repeated injections were required in <z:hpo ids='HP_0000001'>all</z:hpo> patients </plain></SENT>
<SENT sid="6" pm="."><plain>CONCLUSION: Intravitreal triamcinolone acetonide may be beneficial in selected cases of <z:e sem="disease" ids="C0235812" disease_type="Disease or Syndrome" abbrv="">vitritis</z:e> </plain></SENT>
<SENT sid="7" pm="."><plain>This treatment modality has a rapid effect and may lower the use of systemic agents </plain></SENT>
</text></document>